How a New Daily Pill Could Transform Obesity Treatment

May 12, 2026

Reported by

Reviewed by

You May Also Like

What is Orforglipron (Foundayo)?

What is Orforglipron (Foundayo)?

Orforglipron, also known as Foundayo, belongs to a group of drugs called GLP-1 receptor agonists. These help control appetite and blood sugar by mimicking a hormone your body already makes. A simple way to think about it is that it helps you feel full sooner and helps your body handle energy more efficiently.